Biopsy Devices Market to Reach $2,399 Million, Globally, by 2022
The global market is registering a CAGR of 5.5% during the period 2016-2022. Factors that drive the growth of biopsy devices in the developed regions are awareness about cancer diagnosis, high purchasing power, and availability of skilled personnel to perform biopsy procedures.
The global market is registering a CAGR of 5.5% during the period 2016-2022. Factors that drive the growth of biopsy devices in the developed regions are awareness about cancer diagnosis, high purchasing power, and availability of skilled personnel to perform biopsy procedures.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Biopsy</strong> <strong>Devices</strong> market<br />
Opportunity Analysis and Industry Forecast, 2016-2023<br />
Global<br />
Opportunity<br />
Analysis and<br />
Industry Forecast,<br />
2016-<strong>2022</strong>
Introductionof<br />
<strong>Biopsy</strong> <strong>Devices</strong> market<br />
The global market is expected <strong>to</strong> garner <strong>$2</strong>,<strong>399</strong> million <strong>by</strong> <strong>2022</strong>, registering a CAGR of<br />
5.5% during the period 2016-<strong>2022</strong>.<br />
<strong>Biopsy</strong> devices market is owing <strong>to</strong> increase in several types of cancer such, as breast,<br />
prostate, & lung, and rapid technological advancements in the field of diagnostics. The<br />
emerging economies have witnessed an upsurge in the prevalence of chronic diseases<br />
due <strong>to</strong> increase in the aged population and change in lifestyles. The Emergence of<br />
novel biopsy techniques and advanced integrated imaging technology, such as MRI, CT,<br />
ultrasound scan, and others, are expected <strong>to</strong> supplement the diagnosis of chronic<br />
diseases namely, cancer using biopsy procedures. However, high cost associated with<br />
advanced biopsy technologies may restrict the market growth.<br />
North America was the highest revenue generating region due <strong>to</strong> rise in incidences of<br />
chronic diseases in 2015. North America and Europe, collectively, accounted for more<br />
than three-fourths of the overall market in 2015; this trend is likely <strong>to</strong> continue over<br />
the forecast period. Fac<strong>to</strong>rs that drive the growth of biopsy devices in the developed<br />
regions are awareness about cancer diagnosis, high purchasing power, and availability<br />
of skilled personnel <strong>to</strong> perform biopsy procedures.
Introductionof<br />
<strong>Biopsy</strong> <strong>Devices</strong> market<br />
Scope of the Report<br />
Key Benefits<br />
Key Audiences
Key Benefits<br />
1. CT-guided biopsy segment is anticipated <strong>to</strong> grow at the highest CAGR of 6.3%<br />
during the forecast period.<br />
2. The diagnostic centers would continue <strong>to</strong> lead the revenue generating end use<br />
segment <strong>by</strong> garnering around half of the share in the overall market.<br />
3. Lung biopsy is projected <strong>to</strong> be the fastest growing application segment, registering<br />
a CAGR of 7.0%.<br />
4. The robotic guidance system segment is expected <strong>to</strong> register the highest CAGR of<br />
7.0%.<br />
5. The Asia-Pacific region is projected <strong>to</strong> be the fastest growing market, with a CAGR<br />
of 7.2%.<br />
Click <strong>to</strong> Access Full Summary of <strong>Biopsy</strong> <strong>Devices</strong> <strong>Market</strong>
Table of Content (TOC)<br />
Chapter: 1 Introduction<br />
Chapter: 2 Executive Summary<br />
Chapter: 3 <strong>Market</strong> Overview<br />
Chapter: 4 <strong>Market</strong> By Type<br />
Chapter: 5 <strong>Market</strong> By Application<br />
Chapter: 6 <strong>Market</strong> By Image Guided Technology<br />
Chapter: 7 <strong>Market</strong> By End Users<br />
Chapter: 8 Company Profiles
Segments<br />
<strong>Biopsy</strong> <strong>Devices</strong> market<br />
By Device<br />
Type<br />
Segments<br />
By Imaging<br />
Technology<br />
By<br />
Application
Segments<br />
<strong>Biopsy</strong> <strong>Devices</strong> market<br />
Breast biopsy<br />
devices<br />
Robotic biopsy<br />
devices<br />
Gastrointestinal<br />
(GI) biopsy<br />
devices<br />
By Device<br />
Type<br />
Gynaecological<br />
biopsy devices<br />
Soft tissue<br />
biopsy devices<br />
Bronchial<br />
biopsy devices
Segments<br />
<strong>Biopsy</strong> <strong>Devices</strong> market<br />
Breast<br />
biopsy<br />
Gynaecolo<br />
gical<br />
Gastrointe<br />
stinal (GI)<br />
biopsy<br />
Kidney<br />
By<br />
Application<br />
Prostate<br />
Lung<br />
Liver
Segments<br />
<strong>Biopsy</strong> <strong>Devices</strong> market<br />
CT scan<br />
MRI-guided<br />
biopsy<br />
By Imaging<br />
Technology<br />
Stereotacticguided<br />
biopsy<br />
Stereotacticguided<br />
biopsy
Company Profiles<br />
<strong>Biopsy</strong> <strong>Devices</strong> market<br />
1. Leica Biosystems<br />
2. Bos<strong>to</strong>n Scientific Corporation<br />
3. Cook Medical, Inc.<br />
4. Hologic, Inc.<br />
5. Mauna kea technologies.<br />
6. Bec<strong>to</strong>n Dickinson and Company (Carefusion Corp.)
Thank You<br />
<strong>Biopsy</strong> <strong>Devices</strong> market<br />
ThankYou!<br />
For More Details<br />
Do Enquiry<br />
https://www.alliedmarketresearch.com/biopsy-devices-market<br />
Follow Us On
Change language